Cargando…
NASH Therapy: omega 3 supplementation, vitamin E, insulin sensitizers and statin drugs
Non-alcoholic steatohepatitis (NASH) is the more aggressive form of non-alcoholic fatty liver disease (NAFLD). NASH can progress to hepatic fibrosis, cirrhosis, portal hypertension and primary liver cancer. Therapy is evolving with a substantial number of trials of promising new agents now in progre...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Association for the Study of the Liver
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5497667/ https://www.ncbi.nlm.nih.gov/pubmed/28494529 http://dx.doi.org/10.3350/cmh.2017.0103 |